Aurobindo Pharma Shares Drop 3.5% Following Fire at Andhra Pradesh Facility

Aurobindo Pharma Limited shares declined by 3.5% on Tuesday, April 29, following the news of a fire outbreak at its penicillin-G plant in the Kakinada SEZ in Andhra Pradesh during the evening of April 27, 2025...

ASPA MEA Open House 2025 Concludes, Boosts Regional Anti-Counterfeit Ties

The Authentication Solution Providers’ Association (ASPA) successfully hosted its MEA Open House on April 24, 2025, at Anantara Downtown Dubai, bringing together 46 delegates representing 17 companies across the authentication, packaging, and brand p

INTEROR Plans to Strengthen Partnership within India's Pharma Supply Chain

INREROR, the French company, is planning to strengthen ties with Indian pharmaceutical manufacturers.

India Calls for Quick Data on Pharma Exports to Pakistan

In the face of growing tensions in bilateral trade relations, the Department of Pharmaceuticals (DoP) has requested the Pharmaceuticals Export Promotion Council of India (Pharmexcil) to prepare a comprehensive list of medicines and pharmaceuticals...

FDA Review of Novavax COVID Vaccine Raises Doubts about Broader Shot Approval

On Monday, the Food and Drug Administration (FDA) asked Novavax to run a new clinical trial of its vaccine after the agency granted full approval.

ISRO & SCTIMST Partners to deliver Advanced Space Medicine in India

An innovation in Space Medicine has been made through the partnership of the Indian Space Research Organisation (ISRO), Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST),and the Department of S...

Dengue Vaccine 'Qdenga' Set for India Launch in 2026

In India 2026, a Japanese major Takeda, plans to launch a vaccine for dengue, Qdenga, to align with the ‘Make-in-India’, partnering with Hyderabad-based Biological E (Bio E).

Roche's Risdiplam Profits Spark Pricing Debate in India

Pharmaceutical giant Roche is said to have earned profits exceeding a hundredfold the estimated price of taking its spinal muscular atrophy (SMA) medication, risdiplam, to India. Public health organization Knowledge Ecology International (KEI) put...

Piyush Goyal Takes Critical Stance against Evergreening of Patients

In the World Health Summit (WHS) Regional Meeting Asia 2025, Piyush Goyal, Minister of Commerce & Industry criticized pharmaceutical companies for making their patent evergreen. The summit was held in Delhi’s Bharat Manda...

Dr. Reddy's Plans Global GLP-1 Launch as Patents Expire

Dr. Reddy's Laboratories is preparing to enter the rapidly expanding GLP-1 (glucagon-like peptide-1) drug market, hoping to launch generic versions of key diabetes and obesity drugs such as Semaglutide...

© 2025 India Pharma Outlook. All Rights Reserved.